ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $205,937 | -21.9% | 5,775 | -11.2% | 0.11% | -34.7% |
Q4 2022 | $263,640 | +22.6% | 6,500 | 0.0% | 0.17% | +8.3% |
Q3 2022 | $215,000 | -6.1% | 6,500 | 0.0% | 0.16% | -1.9% |
Q2 2022 | $229,000 | -23.7% | 6,500 | -0.4% | 0.16% | -10.1% |
Q1 2022 | $300,000 | -30.7% | 6,525 | 0.0% | 0.18% | -19.8% |
Q4 2021 | $433,000 | +10.2% | 6,525 | +3.7% | 0.22% | +11.0% |
Q3 2021 | $393,000 | +293.0% | 6,295 | +79.9% | 0.20% | +110.5% |
Q1 2020 | $100,000 | -55.9% | 3,500 | -2.5% | 0.10% | -58.1% |
Q4 2019 | $227,000 | – | 3,591 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |